Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Prosight Management, LP
Form 13F · Q2 2026

Prosight Management, LP

CIK 1617201申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$5.8亿
申报组合市值
36
持仓数量
12
Quarters on record
Top 50
持仓数量

Prosight Management, LP——持仓

共 36 个持仓中的前 36 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1LKFT Lakefront Biotherapeutics2.0M+31.8%$6126万10.6%
2JANX Janux Therapeutics Inc3.8M+7.2%$5844万10.1%
3NKTR Nektar Therapeutics810,000+10.2%$5655万9.7%
4BSX Boston Scientific Corp1.3M+59.7%$5422万9.3%
5STTK Shattuck Labs Inc6.0M+19.1%$4135万7.1%
6INSM Insmed Inc375,609—$4005万6.9%
7ALNY Alnylam Pharmaceuticals Inc98,080+29.1%$2953万5.1%
8SNDX Syndax Pharmaceuticals Inc1.2M+55.8%$2623万4.5%
9KURA Kura Oncology Inc2.0M−39.8%$2218万3.8%
10ALKS Alkermes Plc394,389−23.2%$2066万3.6%
11IRTC Irhythm Holdings Inc165,500+1555.0%$1969万3.4%
12VEEV Veeva Sys Inc106,200+22.8%$1885万3.2%
13ZYME Zymeworks Inc674,434+25.1%$1763万3.0%
14ABVX Abivax Sa107,394+2.3%$1431万2.5%
15CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In374,666+7.0%$1402万2.4%
16MLYS Mineralys Therapeutics Inc449,795—$1214万2.1%
17ADCT Adc Therapeutics Sa7.8M−5.7%$837万1.4%
18ICUI Icu Med Inc51,000+85.8%$748万1.3%
19ISRG Intuitive Surgical Inc17,000+325.0%$676万1.2%
20CRBP Corbus Pharmaceuticals Hldgs650,000−6.8%$610万1.1%
21PRCT Procept Biorobotics Corp268,269−86.2%$606万1.0%
22WGS Genedx Holdings Corp85,500−83.7%$587万1.0%
23OPCH Option Care Health Inc270,716—$568万1.0%
24OKUR Onkure Therapeutics Inc978,992−54.6%$446万0.8%
25EBS Emergent Biosolutions Inc459,952−28.0%$385万0.7%
26PFE Pfizer Inc135,366—$326万0.6%
27KIDS Orthopediatrics Corp157,500−47.9%$301万0.5%
28RCKT Rocket Pharmaceuticals Inc700,000+2.4%$239万0.4%
29ANTX An2 Therapeutics Inc474,638−8.0%$230万0.4%
30PLRX Pliant Therapeutics Inc1.4M−17.8%$156万0.3%
31TECX Tectonic Therapeutic Inc39,731−50.3%$137万0.2%
32MGTX Meiragtx Hldgs Plc90,000−96.6%$122万0.2%
33EFOR Everforth Inc67,500—$121万0.2%
34RNTX Rein Therapeutics Inc1.1M+167.2%$114万0.2%
35COYA Coya Therapeutics Inc170,000−59.6%$99万0.2%
36IMRX Immuneering Corp36,861−70.1%$18万0.0%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。